Sagar Cements
Construction
SAGCEM NSE
₹133.15 +2.73 (+2.09%)
- P/E
- Not meaningful: loss-making over the last twelve months
Close 4 Nov 2026 ₹133.15 −89.21 −40.1% 1Y
Start ₹222.36
Key Fundamentals
MicrocapCement & Cement ProductsConstruction MaterialsPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 1.97%
- Debt to Equity
- 1.01
- EPS (TTM)
- −₹2.72
- Book Value
- ₹124.40
- Market Cap
- —
- P/E (TTM)
- Not meaningful: loss-making over the last twelve months
- P/B
- 1.07
- ROE
- −1.05%
- Dividend Yield
- 0.54%
- EBITDA
- ₹314 Cr
- 52W High
- ₹229.09
- 52W Low
- ₹120.60
- Day Range
- ₹128.11 – ₹134.68
- Volume
- 17,891
Peer Comparison
Commodities › Construction › Cement › Cement & Cement Products
| ₹11,816.00 | 39.56 | ₹3,46,219 Cr | 4.73 | 2.05% | 11.10% | 12.70% | ₹95,572 Cr | ₹8,834 Cr | |
| ₹3,138.00 | 37.92 | ₹2,11,790 Cr | 2.05 | 0.32% | 4.98% | 8.01% | ₹1,84,029 Cr | ₹11,261 Cr | |
| ₹375.95 | 21.09 | ₹92,920 Cr | 1.57 | 0.54% | 8.85% | 5.61% | ₹39,867 Cr | ₹5,222 Cr | |
| ₹24,175.00 | 53.51 | ₹86,846 Cr | 3.66 | 0.63% | 7.51% | 10.30% | ₹21,896 Cr | ₹1,637 Cr | |
| ₹5,076.30 | 41.48 | ₹39,409 Cr | 5.34 | 0.39% | 15.60% | 15.10% | ₹14,401 Cr | ₹939 Cr | |
| ₹1,407.00 | 28.29 | ₹26,437 Cr | 1.48 | 0.29% | 6.11% | 7.59% | ₹15,058 Cr | ₹953 Cr | |
| ₹1,185.30 | 11.66 | ₹22,384 Cr | 1.08 | 0.64% | 10.90% | 11.20% | ₹25,442 Cr | ₹1,908 Cr | |
| Sagar Cements (this company) | ₹133.15 | — | ₹1,738 Cr | 1.07 | 0.54% | −1.05% | 1.97% | ₹2,685 Cr | −₹36 Cr |
| Median 8 companies | ₹2,272.50 | 37.92 | ₹63,128 Cr | 1.81 | 0.54% | 8.18% | 9.16% | ₹23,669 Cr | ₹1,773 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
30 Poor
Data confidence 93/100
pledge:30%
Category scores
- Quality
- 35
- Poor
- Returns, margins, earnings quality 22% weight
- Valuation
- 36
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 58
- Good
- Sales & profit trajectory 9% weight
- Financial Health
- 14
- Poor
- Solvency, leverage, coverage 9% weight
- Momentum
- 11
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 36
- Poor
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
1- Stock is trading at 1.01 times its book value
Weaknesses
3- Company has low interest coverage ratio.
- Company has a low return on equity of -5.52% over last 3 years.
- Promoters have pledged 30.0% of their holding.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Bearish | 8 | 5 | 6 |
| Oscillators | Neutral | 2 | 5 | 2 |
| Moving Averages | Strong Bearish | 6 | 0 | 4 |
Oscillators
Neutral
Bearish
2
Neutral
5
Bullish
2
Overall
Bearish
Bearish
8
Neutral
5
Bullish
6
Moving Averages
Strong Bearish
Bearish
6
Neutral
0
Bullish
4
Key readings
- RSI (14)
- 45.25
- Neutral
- MACD (12,26,9)
- −5.59
- Bullish
- SMA (50)
- 145.25
- Bearish
- SMA (200)
- 171.94
- Bearish
As of
Analyst Rating
Based on 5 analysts
2 of 5 analysts rate Buy, 2 Hold, 1 Sell.
As of
BUY
2
40% HOLD
2
40% SELL
1
20% Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | +13.41% |
|---|---|
| 5Y | +14.09% |
| 3Y | +5.92% |
| 1Y | +17.36% |
| TTM | +13.43% |
Net profit
| 10Y | Turned to loss |
|---|---|
| 5Y | Turned to loss |
| 3Y | Turned to loss |
| 1Y | Loss narrowed by ₹216 Cr |
| TTM | Loss narrowed by ₹141 Cr |
Operating cash flow
| 10Y | +5.29% |
|---|---|
| 5Y | −10.54% |
| 3Y | +7.27% |
| 1Y | −7.69% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | −5.31 pp |
|---|---|
| 5Y | −18.16 pp |
| 3Y | +4.16 pp |
| 1Y | +4.78 pp |
| TTM | −0.07 pp |
Revenue by year
| Mar 2017 | ₹814 Cr |
|---|---|
| Mar 2018 | ₹1,038 Cr |
| Mar 2019 | ₹1,218 Cr |
| Mar 2020 | ₹1,175 Cr |
| Mar 2021 | ₹1,371 Cr |
| Mar 2022 | ₹1,597 Cr |
| Mar 2023 | ₹2,230 Cr |
| Mar 2024 | ₹2,505 Cr |
| Mar 2025 | ₹2,258 Cr |
| Mar 2026 | ₹2,650 Cr |
Net profit by year
| Mar 2017 | −₹4.00 Cr |
|---|---|
| Mar 2018 | ₹26.00 Cr |
| Mar 2019 | ₹14.00 Cr |
| Mar 2020 | ₹27.00 Cr |
| Mar 2021 | ₹186 Cr |
| Mar 2022 | ₹59.00 Cr |
| Mar 2023 | ₹8.00 Cr |
| Mar 2024 | −₹52.00 Cr |
| Mar 2025 | −₹217 Cr |
| Mar 2026 | −₹1.00 Cr |
Analyst Forecasts
Forecast For
FY27 consensus · EBITDA
₹337 Cr +7.6% vs FY26
Reported High Mean Low
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 540 | 587 | 669 | 709 | 561 | 475 | 564 | 658 | 671 | 602 | 591 | 787 | 706 | 705 |
| Expenses | 509 | 527 | 582 | 641 | 514 | 455 | 526 | 621 | 549 | 551 | 553 | 705 | 634 | 660 |
| Operating Profit | 30 | 60 | 87 | 68 | 47 | 20 | 38 | 37 | 121 | 51 | 38 | 82 | 72 | 45 |
| OPM % | 6% | 10% | 13% | 10% | 8% | 4.2% | 7% | 6% | 18% | 9% | 6% | 10% | 10% | 6% |
| Other Income | 4 | 18 | 4 | 44 | 8 | 5 | 5 | −24 | 4 | 4 | 2 | 11 | 2 | 2 |
| Interest | 44 | 47 | 49 | 45 | 46 | 46 | 48 | 47 | 47 | 46 | 50 | 53 | 52 | 55 |
| Depreciation | 50 | 51 | 56.21 | 56 | 56 | 58 | 59 | 58 | 55 | 56 | 63 | 66 | 59 | 61 |
| PBT | −59 | −20 | −14.28 | 10 | −48 | −79 | −64 | −93 | 24 | −47 | −74 | −27 | −37 | −69 |
| Tax % | −29% | −48% | −28% | −13% | −32% | −28% | −15% | −21% | 69% | −5% | −13% | −476% | −23% | −25% |
| Net Profit | −42 | −11 | −10 | 12 | −32 | −57 | −54 | −73 | 7 | −44 | −64 | 100 | −28 | −52 |
| EPS (₹) | −3.05 | −0.64 | −0.62 | 1.01 | −2.17 | −4.25 | −4.21 | −5.41 | 0.09 | −3.24 | −4.41 | 6.7 | −1.77 | — |
Sep 2026: from the results filed on 30 Oct 2026, ahead of the full statement, so some rows are blank.
Profit & Loss
₹ Cr| Particulars | Mar 2010 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 425 | 753 | 814 | 1,038 | 1,218 | 1,175 | 1,371 | 1,597 | 2,230 | 2,505 | 2,258 | 2,650 | 2,685 |
| Expenses | 340 | 630 | 703 | 887 | 1,068 | 990 | 971 | 1,321 | 2,076 | 2,258 | 2,116 | 2,358 | 2,442 |
| Operating Profit | 85 | 123 | 110 | 151 | 150 | 186 | 400 | 276 | 153 | 247 | 141 | 292 | 243 |
| OPM % | 20% | 16% | 14% | 15% | 12% | 16% | 29% | 17% | 7% | 10% | 6% | 11% | 9% |
| Other Income | 6 | 4 | 4 | 7 | 2 | 4 | 8 | 13 | 223 | 68 | −6 | 22 | 20 |
| Interest | 30 | 42 | 62 | 59 | 63 | 61 | 47 | 92 | 202 | 185 | 188 | 197 | 202 |
| Depreciation | 29 | 35 | 48 | 54 | 66 | 79 | 81 | 93 | 156 | 214 | 231 | 240 | 244 |
| PBT | 32 | 51 | 4 | 46 | 23 | 50 | 281 | 104 | 18 | −84 | −284 | −123 | −184 |
| Tax % | 37% | 13% | 193% | 42% | 41% | 47% | 34% | 43% | 54% | −38% | −24% | −99% | — |
| Net Profit | 20 | 44 | −4 | 26 | 14 | 27 | 186 | 59 | 8 | −52 | −217 | −1 | −36 |
| EPS (₹) | 2.58 | 5.09 | −0.38 | 2.57 | 1.33 | 2.4 | 15.88 | 5.89 | 2.22 | −3.32 | −16.05 | −0.85 | −2.72 |
| Div. Payout % | 24% | 20% | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. | 31% | 38% | 21% | 8% | 12% | 32% | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. | 0% | 0% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2010 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 15 | 17 | 20 | 20 | 20 | 22 | 24 | 24 | 26 | 26 | 26 | 26 |
| Reserves | 198 | 532 | 743 | 759 | 823 | 944 | 1,167 | 1,232 | 1,611 | 1,915 | 1,697 | 1,667 |
| Borrowings | 231 | 434 | 487 | 478 | 509 | 491 | 809 | 1,510 | 1,478 | 1,444 | 1,446 | 1,708 |
| Other Liabilities | 122 | 264 | 259 | 281 | 375 | 460 | 547 | 583 | 618 | 863 | 952 | 1,069 |
| Total Liabilities | 565 | 1,247 | 1,509 | 1,539 | 1,728 | 1,918 | 2,546 | 3,349 | 3,733 | 4,248 | 4,121 | 4,471 |
| Fixed Assets | 378 | 957 | 1,001 | 1,053 | 1,244 | 1,384 | 1,301 | 2,048 | 2,793 | 3,250 | 3,109 | 3,229 |
| CWIP | 10 | 15 | 55 | 125 | 110 | 108 | 517 | 100 | 99 | 15 | 123 | 116 |
| Investments | 38 | 0 | 0 | 0 | 0 | 0 | 0 | 315 | 0 | 0 | 0 | 0 |
| Other Assets | 139 | 274 | 452 | 361 | 374 | 426 | 727 | 886 | 841 | 983 | 889 | 1,126 |
| Total Assets | 565 | 1,247 | 1,509 | 1,539 | 1,728 | 1,918 | 2,546 | 3,349 | 3,733 | 4,248 | 4,121 | 4,471 |
Cash Flow
₹ Cr| Particulars | Mar 2010 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 126 | 129 | 101 | 150 | 133 | 202 | 377 | 87 | 175 | 400 | 234 | 216 |
| Investing | −40 | −107 | −151 | −194 | −187 | −227 | −476 | −784 | 223 | −188 | −113 | −412 |
| Financing | −95 | −235 | 208 | −77 | 31 | 10 | 322 | 615 | −367 | −221 | −217 | 130 |
| Net Cash Flow | −8 | −214 | 159 | −121 | −23 | −15 | 222 | −82 | 32 | −8 | −97 | −67 |
| Free Cash Flow | 109 | 69 | −43 | −46 | −62 | −25 | −83 | −269 | 59 | 200 | 104 | −201 |
| CFO/EBITDA | 149 | 124 | 96 | 109 | 91 | 114 | 103 | 42 | 124 | 166 | 169 | 74 |
Ratios
| Particulars | Mar 2010 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 36 | 39 | 36 | 33 | 35 | 42 | 27 | 28 | 22 | 30 | 33 | 31 |
| Inventory Days | 209 | 241 | 386 | 239 | 222 | 186 | 189 | 338 | 241 | 273 | 232 | 227 |
| Days Payable | 150 | 353 | 516 | 344 | 312 | 358 | 349 | 358 | 267 | 460 | 278 | 251 |
| Cash Conversion Cycle | 95 | −73 | −95 | −73 | −55 | −130 | −133 | 7 | −4 | −157 | −13 | 7 |
| Working Capital Days | 40 | −57 | −46 | −46 | −59 | −61 | −47 | −45 | −36 | −59 | −108 | −64 |
| ROCE % | 14% | — | 6% | 8% | 7% | 8% | 18% | 8% | 7% | 1% | −2% | 2% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Sagar Cements insights
71 extracted metrics across FY10–FY27.
Documents
- Q1 FY27 concall · Jul 2026PPT
- Q1 FY27 concall · Jul 2026Transcript PPT Recording
- Q4 FY26 concall · May 2026Transcript PPT
- Q3 FY26 concall · Jan 2026Transcript PPT
- Q2 FY26 concall · Oct 2025Transcript PPT
- 2 Jul 2026
- 8 May 2025
- 12 Aug 2024
- 16 Oct 2023
- 31 Mar 2023
- General announcements 2 Nov 2026
- General announcements 30 Oct 2026
- General announcements 23 Oct 2026
Frequently Asked Questions about Sagar Cements
What does Sagar Cements Ltd do?
Sagar Cements is engaged in the business of manufacture and sale of cement.
Where is Sagar Cements Ltd (SAGCEM) listed?
Sagar Cements Ltd trades as SAGCEM on the NSE and under code 502090 on the BSE.
Which sector does Sagar Cements Ltd belong to?
Sagar Cements Ltd is classified under the Construction sector, in the Cement industry.
What is the 52-week high and low of Sagar Cements Ltd?
Over the last 52 weeks Sagar Cements Ltd has traded between ₹120.6 and ₹229.09 as of 4 Nov 2026.
Does Sagar Cements Ltd pay dividends?
Sagar Cements Ltd has a dividend yield of 0.54%.
What is the Return on Equity (ROE) of Sagar Cements Ltd?
Sagar Cements Ltd reported a return on equity of -1.05%. Its debt-to-equity ratio is 1.01.
Company Information
Sagar Cements is engaged in the business of manufacture and sale of cement.
Website sagarcements.in
CEO Dr. Anand Reddy Sammidi M.B.B.S., M.D.
Employees 1,202
Listed 29 Jan 2007
Face Value ₹2
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/SAGCEM.md for Sagar Cements Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.